| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-10 |
| mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
5e-10 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-07 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-06 |
| mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
9e-05 |
| mRNA |
681640 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0005 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.001 |
| mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.002 |